Manatuck Hill Partners’s Biogen BIIB Stock Holding History

Manatuck Hill Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-37,700	Closed	-$8.11M	–	99
2013 Q2	$8.11M	Buy	+37,700	New	+$8.06M	0.99%	32

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manatuck Hill Partners's BIIB Position: Q3 2013 in Review

Manatuck Hill Partners sold out of Biogen (BIIB) in Q3 2013, closing a stake of 37,700 shares — an estimated $8.11M sold.

Manatuck Hill Partners first reported a position in BIIB in Q2 2013 and held it in 1 quarter. The position peaked at $8.11M in Q2 2013. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

Manatuck Hill Partners reported no remaining Biogen position as of Q3 2013 after selling out during the quarter.
Manatuck Hill Partners sold 37,700 Biogen shares in Q3 2013, an estimated $8.11M.
Manatuck Hill Partners first reported a position in Biogen in Q2 2013 and held it in 1 quarter.
Manatuck Hill Partners's Biogen position peaked at $8.11M in Q2 2013.
656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Manatuck Hill Partners's 13F filing for Q3 2013, filed 14 Nov 2013.